Caplin Point Laboratories informs about press release

24 Feb 2026 Evaluate
Caplin Point Laboratories has informed that it enclosed press release regarding receipt of final approval by Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1698.85 -27.35 (-1.58%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×